Middle East, North Africa, Afghanistan & Pakistan (excluding high income) vs Tajikistan: Immunization, measles second dose

Middle East, North Africa, Afghanistan & Pakistan (excluding high income)
79.9%
in 2024
Tajikistan
97.0%
in 2024
Middle East, North Africa, Afghanistan & Pakistan (excluding high income) rank
22nd
Tajikistan rank
19th

Immunization, measles second dose over time

  • Middle East, North Africa, Afghanistan & Pakistan (excluding high income)
  • Tajikistan
406080100199920112024

How they compare

Tajikistan currently reports 97.0% against 79.9% in Middle East, North Africa, Afghanistan & Pakistan (excluding high income), a difference of 17.1%.

That makes Tajikistan's figure about 1.2 times Middle East, North Africa, Afghanistan & Pakistan (excluding high income)'s.

Across all 25 years both countries report, Tajikistan has been ahead every year.

Middle East, North Africa, Afghanistan & Pakistan (excluding high income) ranks 22nd and Tajikistan ranks 19th of 43 groups.

Tajikistan has averaged higher in every one of the 3 decades both report.

Head to head by decade

Decade Middle East, North Africa, Afghanistan & Pakistan (excluding high income) Tajikistan Difference Ahead
2000s 42.0% 87.4% 45.4% Tajikistan
2010s 67.7% 96.6% 28.9% Tajikistan
2020s 78.3% 96.6% 18.3% Tajikistan

Averages of every year both report within each decade.

Frequently asked questions

Which has higher immunization, measles second dose, Middle East, North Africa, Afghanistan & Pakistan (excluding high income) or Tajikistan?
Tajikistan, at 97.0% against 79.9% in Middle East, North Africa, Afghanistan & Pakistan (excluding high income) as of 2024.
What is the difference in immunization, measles second dose between Middle East, North Africa, Afghanistan & Pakistan (excluding high income) and Tajikistan?
17.1%, with Tajikistan ahead.
How many years of comparable data are there for Middle East, North Africa, Afghanistan & Pakistan (excluding high income) and Tajikistan?
25 years are reported by both, from 2000 to 2024.
How do Middle East, North Africa, Afghanistan & Pakistan (excluding high income) and Tajikistan rank globally for immunization, measles second dose?
Middle East, North Africa, Afghanistan & Pakistan (excluding high income) ranks 22nd and Tajikistan ranks 19th of 43 groups.
Where does this data come from?
WHO and UNICEF (http://www.who.int/immunization/monitoring_surveillance/en/), published as Immunization, measles second dose (% of children by the nationally recommended age). Statizoid refreshes it automatically from the source and publishes the full history for both places.

Individual pages

Share, cite or embed this page

Cite this page

Middle East, North Africa, Afghanistan & Pakistan (excluding high income) vs Tajikistan: Immunization, measles second dose. Statizoid, drawing on WHO and UNICEF (http://www.who.int/immunization/monitoring_surveillance/en/). Retrieved 19 September 2026, from https://health.statizoid.com/compare/immunization-measles-second-dose-percent-of-children-by-the-nationally-recommended-age/middle-east-north-africa-afghanistan-and-pakistan-excluding-high-income/tajikistan/

Embed or link this data

Paste this into a page to link back to these figures. The data itself is free to reuse under CC BY 4.0 (World Bank Open Data); please keep the attribution.

<a href="https://health.statizoid.com/compare/immunization-measles-second-dose-percent-of-children-by-the-nationally-recommended-age/middle-east-north-africa-afghanistan-and-pakistan-excluding-high-income/tajikistan/">Middle East, North Africa, Afghanistan & Pakistan (excluding high income) vs Tajikistan: Immunization, measles second dose</a> — Statizoid

About this data

Indicator
Immunization, measles second dose (% of children by the nationally recommended age)
Unit
% of children by the nationally recommended age
Source
WHO and UNICEF (http://www.who.int/immunization/monitoring_surveillance/en/)
Licence
CC BY 4.0 (World Bank Open Data)
Coverage
221 places, 4,472 data points, 1997–2024
Last refreshed

Child immunization, measles second dose, measures the percentage of children who received two dose of measles containing vaccine according to nationally recommended schedule through routine immunization services in a given year.